Elucid Bioimaging

Boston, MA · Privately Held (backing)

Developer of an imaging system designed to improve patient outcomes at a reduced cost by applying artificial intelligence to vascular diagnostic imaging. Elucid Bioimaging is based in Boston, MA. It was valued at $288 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $163 million across 3 recorded rounds; the latest was a $36.5 million early-stage round in Oct 2025.

PMV mark · valuation
$288.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$163.2M
Last round
Early Stage VC
Oct 2025

Who backs Elucid Bioimaging?

24 investors
InvestorType
Sand Hill AngelsVenture capital
IAG Capital PartnersVenture capital
University of Michigan EndowmentOther
Elevage Medical Technologies—
Angel Physicians Fund—
Aphelion Capital—
Bioverge Ventures—
Biovision Ventures—
BlueStone Venture Partners—
Bold Brain Capital—
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Elucid Bioimaging investors

24 investors are on record for Elucid Bioimaging, including Sand Hill Angels, IAG Capital Partners, University of Michigan Endowment and Elevage Medical Technologies. The early-stage round in Oct 2025 drew 9 investors.

Free account
More of Elucid Bioimaging with a free account
  • ·The complete investor list: 24 names
  • ·Watch Elucid Bioimaging: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like Elucid Bioimaging. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View